T0	Participants 101 152	patients undergoing coronary artery bypass surgery.
T1	Participants 277 341	patients undergoing coronary artery bypass graft surgery (CABG).
T2	Participants 342 462	Sixty patients (age 40-73 yr, 56 male) were assigned randomly to receive alfentanil, fentanyl or sufentanil and propofol
T3	Participants 1410 1434	patients undergoing CABG